stars 1 stars 2 stars 3

Kintor Pharmaceutical Limited is developing and commercializing a robust pipeline of innovative small molecule and biological therapeutics for androgen-receptor and tumor-related disease areas with unmet medical needs, including COVID-19, prostate, breast and liver cancers, alopecia and acne. For more information, visit www.kintor.com.cn.

Website https://www.kintor.com.cn/
Revenue $6.4 million
Employees 29 (9 on RocketReach)
Founded 2009
Phone +86 512 6295 6307
Technologies
Industry Biotechnology, Pharmaceutical Manufacturing, Biopharma, Drug Discovery, Health Care, Science and Engineering, Life Science, Pharmaceutical
Competitors Apexigen, AstraZeneca, Bayer, CanSino Biologics Inc.康希诺生物, WuXi AppTec, 百济神州医药信息咨询(上海)有限公司, Sino Biopharmaceutical Limited, Innovent Biologics, Eisai Co., Ltd., Bristol Myers Squibb +43 more (view full list)

Kintor Pharmaceutical Limited Questions

The Kintor Pharmaceutical Limited annual revenue was $6.4 million in 2026.

Luke Cheung is the CFO of Kintor Pharmaceutical Limited.

9 people are employed at Kintor Pharmaceutical Limited.

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users